Indiana University Melvin and Bren Simon Cancer Center Support Grant

印第安纳大学梅尔文和布伦西蒙癌症中心支持补助金

• 批准号: 7931041
• 负责人: PATRICK J. LOEHRER
• 金额: $ 4.95万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2012-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7931041
• 关键词: Indiana; University; Melvin; Bren; Simon

DESCRIPTION (provided by applicant): The Indiana University Melvin and Bren Simon Cancer Center is a matrix Cancer Center that organizes and facilitates cancer research, education, patient care, and cancer control and prevention. Our mission is to advance the understanding, prevention and treatment of cancer throughout Indiana and the world with patient centered care, acceleration of promising science and collaborative educational programs. This application seeks funds for the Center's four research programs, six shared facilities, Protocol-Specific Research, Protocol Review and Monitoring System, and Data and Safety Monitoring. In addition, funds are requested for Administration, Program Planning and Evaluation, Developmental Funds, and Senior Leaders. The research programs have been organized and developed to be highly interactive, allowing for successful collaboration among basic, clinical, and population science researchers. The research programs are: 1) Cancer Control, 2) Breast Cancer, 3) Experimental and Developmental Therapeutics, 4) Hematopoiesis, Microenvironment and Immunology. Supporting the members of these programs are six shared resources: Biological Microscopy, Biostatistics and Data Management, Clinical Research Office, Flow Cytometry, Chemical Genomics and Clinical Pharmacology Analytical Analysis.

描述（由申请人提供）：印第安纳大学梅尔文和布伦·西蒙癌症中心是一个基质癌症中心，可组织和促进癌症研究，教育，患者护理以及癌症控制和预防。我们的任务是通过以患者为中心的护理，有前途的科学和协作教育计划来提高印第安纳州和世界各地癌症的理解，预防和治疗。该应用程序为中心的四个研究计划，六个共享设施，特定于协议的研究，协议审查和监视系统以及数据和安全监控寻求资金。此外，还请求资金进行管理，计划计划和评估，发展基金和高级领导人。该研究计划的组织和开发是高度互动的，可以在基础，临床和人群科学研究人员之间成功合作。研究计划是：1）癌症控制，2）乳腺癌，3）实验和发育疗法，4）造血，微环境和免疫学。支持这些计划的成员是六个共享资源：生物学显微镜，生物统计学和数据管理，临床研究办公室，流式细胞仪，化学基因组学和临床药理学分析分析。